ACLX Arcellx | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $52.42 -0.5% | $81.00 | Buy ➝ Buy | |
ACM AECOM | Target Raised by | Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $93.14 -3.3% | $104.00 ➝ $110.00 | Outperform ➝ Outperform | |
ADCT ADC Therapeutics | Target Lowered by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $4.83 +8.5% | $9.00 ➝ $8.00 | Buy ➝ Buy | |
ADEA Adeia | Reiterated by | BWS Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $11.03 +10.4% | $16.00 ➝ $16.00 | Buy ➝ Buy | |
ADNT Adient | Target Lowered by | Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $27.74 -1.4% | $37.00 ➝ $34.00 | Equal Weight ➝ Equal Weight | |
ADUS Addus HomeCare | Reiterated by | Stephens Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $104.59 +6.8% | $115.00 | Overweight ➝ Overweight | |
|
ADUS Addus HomeCare | Target Raised by | Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $104.59 +6.8% | $115.00 ➝ $118.00 | Buy ➝ Buy | |
AGEN Agenus | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $12.01 -7.3% | $40.00 | Buy ➝ Buy | |
AL Air Lease | Target Lowered by | TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $47.79 -7.3% | $59.00 ➝ $56.00 | Buy ➝ Buy | |
ALB Albemarle | Target Raised by | Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $131.55 +0.6% | $125.00 ➝ $140.00 | Hold ➝ Hold | |
ALG Alamo Group | Target Lowered by | DA Davidson Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $194.07 +0.4% | $235.00 ➝ $225.00 | Buy ➝ Buy | |
ALNY Alnylam Pharmaceuticals | Target Raised by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $154.33 +2.1% | $395.00 ➝ $400.00 | Buy ➝ Buy | |
ALTO Alto Ingredients | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $1.76 -9.7% | $5.50 | Buy ➝ Buy | |
AMD Advanced Micro Devices | Upgraded by | DZ Bank Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $154.43 -0.9% | $190.00 | Hold ➝ Buy | |
AMG Affiliated Managers Group | Reiterated by | Barrington Research Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $155.56 -1.1% | $190.00 ➝ $190.00 | Outperform ➝ Outperform | |
AMG Affiliated Managers Group | Target Lowered by | TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $155.56 -1.1% | $218.00 ➝ $198.00 | Buy ➝ Buy | |
AMR Alpha Metallurgical Resources | Target Raised by | B. Riley Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $304.57 +2.7% | $374.00 ➝ $375.00 | Buy ➝ Buy | |
AMR Alpha Metallurgical Resources | Reiterated by | Benchmark Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $304.57 +2.7% | | Hold | |
AORT Artivion | Target Raised by | Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $23.77 +12.8% | $22.00 ➝ $25.00 | Buy ➝ Buy | |
AORT Artivion | Target Raised by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $23.77 +12.8% | $25.00 ➝ $30.00 | Buy ➝ Buy | |
APA APA | Target Raised by | Susquehanna Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $30.26 +1.1% | $54.00 ➝ $57.00 | Positive ➝ Positive | |
APTV Aptiv | Target Raised by | JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $83.00 -1.7% | $109.00 ➝ $113.00 | Overweight ➝ Overweight | |
ARES Ares Management | Initiated by | TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $137.29 +0.8% | $154.00 | Buy | |
ASH Ashland | Target Raised by | BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $98.02 +0.7% | $97.00 ➝ $105.00 | Market Perform ➝ Market Perform | |
AVNS Avanos Medical | Reiterated by | JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $19.54 -1.0% | | Market Perform | |
AXON Axon Enterprise | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $312.73 -4.6% | $400.00 | Buy ➝ Buy | |
AXON Axon Enterprise | Reiterated by | JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $312.73 -4.6% | $375.00 | Market Outperform ➝ Market Outperform | |
AXON Axon Enterprise | Target Raised by | Craig Hallum Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $312.73 -4.6% | $325.00 ➝ $370.00 | Buy ➝ Buy | |
AXSM Axsome Therapeutics | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $76.94 +1.3% | $190.00 | Buy ➝ Buy | |
AXSM Axsome Therapeutics | Target Raised by | Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $76.94 +1.3% | $108.00 ➝ $112.00 | Outperform ➝ Outperform | |
AXSM Axsome Therapeutics | Target Lowered by | Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $76.94 +1.3% | $127.00 ➝ $125.00 | Buy ➝ Buy | |
AZO AutoZone | Target Lowered by | Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $2,990.65 +0.8% | $3,505.00 ➝ $3,420.00 | Buy ➝ Buy | |
BABA Alibaba Group | Target Lowered by | Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $79.37 -2.7% | $114.00 ➝ $113.00 | Buy ➝ Buy | |
BBY Best Buy | Target Lowered by | Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $73.06 -1.8% | $76.00 ➝ $67.00 | Sell ➝ Sell | |
BCRX BioCryst Pharmaceuticals | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $5.26 -0.2% | $30.00 | Buy ➝ Buy | |
BCRX BioCryst Pharmaceuticals | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $5.26 -0.2% | $12.00 | Buy ➝ Buy | |
BCRX BioCryst Pharmaceuticals | Target Raised by | JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $5.26 -0.2% | $14.00 ➝ $15.00 | Market Outperform ➝ Market Outperform | |
BKNG Booking | Target Raised by | HSBC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $3,605.41 +0.2% | $4,220.00 ➝ $4,230.00 | Buy ➝ Buy | |
BNTX BioNTech | Target Lowered by | BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $90.88 -2.6% | $123.00 ➝ $122.00 | Outperform ➝ Outperform | |
BNTX BioNTech | Target Raised by | TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $90.88 -2.6% | $95.00 ➝ $98.00 | Hold ➝ Hold | |
Dave Ramsey Shocks Millions With US Dollar Lunacy (Ad) Dave Ramsey Is Dangerously Wrong And Here’s Why>>
Asked whether we’re on the cusp of a US Dollar crash, Dave Ramsey made a stunning miscalculation while live on air:
“Am I worried about this? Absolutely not.”
Frankly, I've never seen someone so confident in being wrong…
Because what’s happening to the US Dollar is not something you should “keep an eye on”…
But instead, is an imminent threat you should get ahead of right NOW. GET THE FREE GUIDE |
BODI Beachbody | Target Lowered by | Roth Mkm Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $8.80 -6.8% | $15.00 ➝ $14.00 | Buy ➝ Buy | |
BODI Beachbody | Target Lowered by | Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $8.80 -6.8% | $12.00 ➝ $10.00 | Neutral ➝ Neutral | |
BOWL Bowlero | Target Lowered by | Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $11.27 +0.6% | $18.00 ➝ $15.00 | Outperform ➝ Outperform | |
BOWL Bowlero | Target Lowered by | Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $11.27 +0.6% | $19.00 ➝ $17.00 | Buy ➝ Buy | |
BOWL Bowlero | Target Lowered by | Roth Mkm Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $11.27 +0.6% | $17.00 ➝ $15.00 | Buy ➝ Buy | |
BOWL Bowlero | Reiterated by | CJS Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $11.27 +0.6% | | Market Outperform ➝ Market Perform | |
BOWL Bowlero | Target Lowered by | Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $11.27 +0.6% | $20.00 ➝ $18.00 | Buy ➝ Buy | |
BOWL Bowlero | Target Lowered by | B. Riley Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $11.27 +0.6% | $19.00 ➝ $17.00 | Buy ➝ Buy | |
BOWL Bowlero | Target Raised by | Craig Hallum Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $11.27 +0.6% | $17.00 ➝ $18.00 | Buy ➝ Buy | |
BRBR BellRing Brands | Reiterated by | Stephens Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $58.44 +2.2% | $53.00 | Equal Weight ➝ Equal Weight | |
BRBR BellRing Brands | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $58.44 +2.2% | $62.00 | Buy ➝ Buy | |
BWXT BWX Technologies | Target Lowered by | Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $87.04 -12.0% | $111.00 ➝ $110.00 | Buy ➝ Buy | |
CART Maplebear | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $37.52 +2.7% | | Hold | |
CART Maplebear | Reiterated by | Benchmark Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $37.52 +2.7% | | Hold | |
CB Chubb | Target Lowered by | Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $251.95 0.0% | $297.00 ➝ $294.00 | Outperform ➝ Outperform | |
CBT Cabot | Target Raised by | UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $101.07 +5.3% | $100.00 ➝ $103.00 | Neutral ➝ Neutral | |
CBT Cabot | Target Raised by | Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $101.07 +5.3% | $104.00 ➝ $109.00 | Buy ➝ Buy | |
CCI Crown Castle | Target Lowered by | Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $96.15 +0.2% | $109.00 ➝ $100.00 | Sector Perform ➝ Sector Perform | |
CF CF Industries | Target Lowered by | Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $74.99 +0.6% | $82.00 ➝ $75.00 | Underweight ➝ Underweight | |
CGNX Cognex | Reiterated by | Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $45.90 +3.2% | $47.00 ➝ $50.00 | Buy ➝ Buy | |
CGNX Cognex | Upgraded by | HSBC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $45.90 +3.2% | $52.00 | Hold ➝ Buy | |
CHWY Chewy | Target Lowered by | Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $15.49 -3.1% | $18.00 ➝ $16.00 | Neutral ➝ Neutral | |
CIFR Cipher Mining | Target Raised by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $3.79 -15.2% | $4.50 ➝ $5.50 | Buy ➝ Buy | |
CLDX Celldex Therapeutics | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $42.21 +1.3% | $80.00 | Buy ➝ Buy | |
CLSK CleanSpark | Reiterated by | Chardan Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $16.54 -5.1% | $26.00 ➝ $26.00 | Buy ➝ Buy | |
CMPO CompoSecure | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $7.53 +3.9% | $15.00 | Buy ➝ Buy | |
CMPO CompoSecure | Target Raised by | Benchmark Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $7.53 +3.9% | $8.00 ➝ $10.00 | Buy ➝ Buy | |
CMPR Cimpress | Reiterated by | Barrington Research Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $84.24 +1.0% | $113.00 ➝ $113.00 | Outperform ➝ Outperform | |
COTY Coty | Target Lowered by | DA Davidson Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $11.10 -3.5% | $17.50 ➝ $16.50 | Buy ➝ Buy | |
CPG Crescent Point Energy | Target Raised by | BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $8.85 +0.3% | $13.00 ➝ $14.00 | Outperform ➝ Outperform | |
CRNT Ceragon Networks | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $2.77 -12.1% | $5.25 | Buy ➝ Buy | |
CRNX Crinetics Pharmaceuticals | Target Raised by | Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $47.66 +2.5% | $56.00 ➝ $97.00 | Overweight ➝ Overweight | |
CRVS Corvus Pharmaceuticals | Target Raised by | Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $1.68 -12.0% | $7.00 ➝ $8.00 | Outperform ➝ Outperform | |
CTRA Coterra Energy | Target Raised by | Susquehanna Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $28.08 -1.0% | $32.00 ➝ $33.00 | Positive ➝ Positive | |
CTSO Cytosorbents | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | S. Lee Subscribe to MarketBeat All Access for the recommendation accuracy rating | $0.93 +0.2% | $1.00 | Neutral ➝ Neutral | |
CVS CVS Health | Downgraded by | TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $55.74 -0.4% | $99.00 ➝ $59.00 | Buy ➝ Hold | |
CVS CVS Health | Target Lowered by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $55.74 -0.4% | $76.00 ➝ $60.00 | Equal Weight ➝ Equal Weight | |
DAWN Day One Biopharmaceuticals | Target Lowered by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $17.08 +2.9% | $50.00 ➝ $40.00 | Buy ➝ Buy | |
DAWN Day One Biopharmaceuticals | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $17.08 +2.9% | $33.00 | Buy ➝ Buy | |
DAWN Day One Biopharmaceuticals | Reiterated by | Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $17.08 +2.9% | $33.00 | Outperform | |
DDOG Datadog | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $112.40 -11.5% | $165.00 | Buy ➝ Buy | |
DHI D.R. Horton | Target Raised by | Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the recommendation accuracy rating | J. Rahmani Subscribe to MarketBeat All Access for the recommendation accuracy rating | $151.40 +0.1% | $172.00 ➝ $178.00 | Outperform ➝ Outperform | |
DIS Walt Disney | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $105.39 -9.5% | $145.00 | Buy ➝ Buy | |
DSGN Design Therapeutics | Upgraded by | Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $4.69 +28.5% | $6.00 ➝ $12.00 | Neutral ➝ Overweight | |
ED Consolidated Edison | Target Raised by | Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $97.50 +1.4% | $89.00 ➝ $97.00 | Equal Weight ➝ Equal Weight | |
ELDN Eledon Pharmaceuticals | Target Raised by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $2.26 -7.4% | $13.00 ➝ $16.00 | Buy ➝ Buy | |
ENTA Enanta Pharmaceuticals | Target Lowered by | JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $13.10 -10.3% | $23.00 ➝ $22.00 | Market Outperform ➝ Market Outperform | |
ENTA Enanta Pharmaceuticals | Target Lowered by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $13.10 -10.3% | $28.00 ➝ $27.00 | Buy ➝ Buy | |
EOG EOG Resources | Reiterated by | Benchmark Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $130.26 -0.2% | | Hold | |
EQH Equitable | Target Raised by | Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $39.43 +0.7% | $41.00 ➝ $43.00 | Market Perform ➝ Market Perform | |
Trump Asset Seizure Threat Alert: Could Your Savings Be Next? (Ad) Trump Asset Seizures Threat A Warning For 401K Owners? Request Your FREE WEALTH PROTECTION GUIDE |
ESPR Esperion Therapeutics | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $2.37 +11.8% | $8.00 | Buy ➝ Buy | |
EVER EverQuote | Target Raised by | B. Riley Subscribe to MarketBeat All Access for the recommendation accuracy rating | D. Day Subscribe to MarketBeat All Access for the recommendation accuracy rating | $25.29 +18.4% | $24.00 ➝ $29.50 | Buy ➝ Buy | |
EVER EverQuote | Target Raised by | Craig Hallum Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $25.29 +18.4% | $26.00 ➝ $30.00 | Buy ➝ Buy | |
EVER EverQuote | Target Raised by | Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $25.29 +18.4% | $25.00 ➝ $30.00 | Buy ➝ Buy | |
EVER EverQuote | Target Raised by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $25.29 +18.4% | $25.00 ➝ $30.00 | Buy ➝ Buy | |
EW Edwards Lifesciences | Target Raised by | Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $85.84 +0.9% | $100.00 ➝ $101.00 | Overweight ➝ Overweight | |
EXPE Expedia Group | Target Lowered by | HSBC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $112.91 -2.7% | $166.00 ➝ $132.00 | Hold ➝ Hold | |
EYPT EyePoint Pharmaceuticals | Target Lowered by | Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $11.87 +6.0% | $39.00 ➝ $30.00 | Buy ➝ Buy | |
EYPT EyePoint Pharmaceuticals | Target Lowered by | Chardan Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $11.87 +6.0% | $39.00 ➝ $28.00 | Buy ➝ Buy | |
FAST Fastenal | Target Lowered by | Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $66.41 -0.5% | $71.00 ➝ $69.00 | Neutral ➝ Neutral | |
FHTX Foghorn Therapeutics | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $5.63 -3.4% | $20.00 | Buy ➝ Buy | |
FIS Fidelity National Information Services | Reiterated by | William Blair Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $74.31 +5.5% | | Outperform | |
FIS Fidelity National Information Services | Target Raised by | Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $74.31 +5.5% | $75.00 ➝ $82.00 | Outperform ➝ Outperform | |
FIS Fidelity National Information Services | Reiterated by | Stephens Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $74.31 +5.5% | $90.00 | Overweight ➝ Overweight | |
FIS Fidelity National Information Services | Target Raised by | Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $74.31 +5.5% | $78.00 ➝ $82.00 | Neutral ➝ Neutral | |
FIS Fidelity National Information Services | Target Raised by | Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $74.31 +5.5% | $75.00 ➝ $80.00 | In-Line ➝ In-Line | |
FMC FMC | Target Raised by | Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $66.75 +9.5% | $55.00 ➝ $57.00 | Neutral ➝ Neutral | |
FN Fabrinet | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $209.31 +10.8% | $220.00 | Buy ➝ Buy | |
FN Fabrinet | Target Lowered by | B. Riley Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $209.31 +10.8% | $173.00 ➝ $171.00 | Neutral ➝ Neutral | |
FRPT Freshpet | Target Raised by | TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $120.70 -0.3% | $128.00 ➝ $143.00 | Buy ➝ Buy | |
FRPT Freshpet | Target Raised by | Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $120.70 -0.3% | $125.00 ➝ $135.00 | Outperform ➝ Outperform | |
FRPT Freshpet | Target Raised by | DA Davidson Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $120.70 -0.3% | $138.00 ➝ $153.00 | Buy ➝ Buy | |
FRPT Freshpet | Target Raised by | Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $120.70 -0.3% | $120.00 ➝ $135.00 | Outperform ➝ Outperform | |
FRPT Freshpet | Target Raised by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $120.70 -0.3% | $124.00 ➝ $140.00 | Overweight ➝ Overweight | |
FULT Fulton Financial | Target Raised by | Stephens Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $17.06 +0.4% | $15.50 ➝ $17.50 | Equal Weight ➝ Equal Weight | |
FYBR Frontier Communications Parent | Target Raised by | Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $25.82 -1.8% | $30.00 ➝ $32.00 | Buy ➝ Buy | |
GHRS GH Research | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $12.08 +3.3% | $40.00 | Buy ➝ Buy | |
GLW Corning | Initiated by | Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $33.42 -0.1% | $36.00 | Neutral | |
GPRE Green Plains | Reiterated by | Stephens Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $19.28 -3.1% | $24.00 | Equal Weight ➝ Equal Weight | |
GPRE Green Plains | Target Lowered by | Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $19.28 -3.1% | $29.00 ➝ $26.00 | Buy ➝ Buy | |
GPS GAP | Upgraded by | Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $22.11 -0.5% | $21.00 ➝ $28.00 | Neutral ➝ Buy | |
GROV Grove Collaborative | Reiterated by | Telsey Advisory Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $1.65 +2.5% | $3.00 ➝ $3.00 | Outperform ➝ Outperform | |
GS The Goldman Sachs Group | Target Raised by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $443.80 +0.0% | $450.00 ➝ $504.00 | Overweight ➝ Overweight | |
HALO Halozyme Therapeutics | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $41.21 +0.9% | $50.00 | Buy ➝ Buy | |
HD Home Depot | Reiterated by | Telsey Advisory Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $340.69 -0.5% | $360.00 ➝ $360.00 | Market Perform ➝ Market Perform | |
HD Home Depot | Target Lowered by | Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $340.69 -0.5% | $415.00 ➝ $395.00 | Buy ➝ Buy | |
HIMS Hims & Hers Health | Target Raised by | Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $12.35 +6.0% | $14.00 ➝ $16.00 | Hold ➝ Hold | |
HIMS Hims & Hers Health | Target Raised by | Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $12.35 +6.0% | $11.00 ➝ $13.00 | Neutral ➝ Neutral | |
HMST HomeStreet | Target Lowered by | Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $10.48 -2.0% | $15.50 ➝ $13.50 | Market Perform ➝ Market Perform | |
HPP Hudson Pacific Properties | Target Lowered by | The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $5.22 -3.9% | $9.00 ➝ $7.00 | Neutral ➝ Neutral | |
HSII Heidrick & Struggles International | Target Raised by | Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $29.42 -2.9% | $30.00 ➝ $33.00 | Hold ➝ Hold | |
HUN Huntsman | Target Raised by | Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $25.34 +2.3% | $24.00 ➝ $26.00 | Sector Perform ➝ Sector Perform | |
HUT Hut 8 | Reiterated by | Benchmark Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $8.19 -7.5% | $12.00 | Buy ➝ Buy | |
IART Integra LifeSciences | Target Lowered by | Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $25.08 +8.4% | $37.00 ➝ $25.00 | Hold ➝ Hold | |
IART Integra LifeSciences | Target Lowered by | JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $25.08 +8.4% | $49.00 ➝ $40.00 | Market Outperform ➝ Market Outperform | |
IART Integra LifeSciences | Target Lowered by | Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $25.08 +8.4% | $42.00 ➝ $26.00 | Underperform ➝ Underperform | |
IART Integra LifeSciences | Downgraded by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $25.08 +8.4% | $45.00 ➝ $25.00 | Overweight ➝ Equal Weight | |
IART Integra LifeSciences | Downgraded by | Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $25.08 +8.4% | | Outperform ➝ Market Perform | |
IART Integra LifeSciences | Target Lowered by | Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $25.08 +8.4% | $37.00 ➝ $24.00 | Underweight ➝ Underweight | |
IAS Integral Ad Science | Reiterated by | Benchmark Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $9.90 -0.7% | | Hold | |
AI “wealth window” is closing June 25th (Ad) Today, I’m making my boldest prediction ever.
Next-generation AI technology will create the first $100 TRILLION industry. I put together this personal video [HERE]… |
IFF International Flavors & Fragrances | Target Raised by | Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $94.33 +6.4% | $87.00 ➝ $95.00 | Hold ➝ Hold | |
IFF International Flavors & Fragrances | Target Raised by | Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $94.33 +6.4% | $91.00 ➝ $98.00 | Neutral ➝ Neutral | |
ILMN Illumina | Reiterated by | Stephens Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $112.82 -5.2% | $170.00 | Overweight ➝ Overweight | |
INTT inTEST | Target Lowered by | Lake Street Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $10.79 -7.7% | $19.00 ➝ $16.00 | Buy ➝ Buy | |
ITCI Intra-Cellular Therapies | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $71.21 +0.3% | $90.00 | Buy | |
JJSF J&J Snack Foods | Reiterated by | Benchmark Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $160.47 +16.4% | $195.00 | Buy ➝ Buy | |
KIDS OrthoPediatrics | Reiterated by | JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $34.70 +3.3% | $50.00 | Market Outperform ➝ Market Outperform | |
KIDS OrthoPediatrics | Target Raised by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $34.70 +3.3% | $37.00 ➝ $42.00 | Buy ➝ Buy | |
KSPI Joint Stock Company Kaspi.kz | Initiated by | New Street Research Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $120.52 +0.2% | $175.00 | Buy | |
LBPH Longboard Pharmaceuticals | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $22.05 +7.0% | $60.00 | Buy ➝ Buy | |
LCID Lucid Group | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $2.62 -14.1% | | Hold | |
LHX L3Harris Technologies | Target Raised by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $215.91 +0.5% | $238.00 ➝ $245.00 | Overweight ➝ Overweight | |
LILA Liberty Latin America | Target Lowered by | Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $8.21 +0.9% | $9.00 ➝ $8.00 | Equal Weight ➝ Equal Weight | |
LINC Lincoln Educational Services | Target Raised by | Lake Street Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $11.90 -2.7% | $14.00 ➝ $15.00 | Buy ➝ Buy | |
LINC Lincoln Educational Services | Target Raised by | B. Riley Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $11.90 -2.7% | $14.00 ➝ $15.00 | Buy ➝ Buy | |
LITE Lumentum | Target Lowered by | B. Riley Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $41.40 -6.1% | $41.00 ➝ $40.00 | Neutral ➝ Neutral | |
LITE Lumentum | Target Lowered by | Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $41.40 -6.1% | $40.00 ➝ $38.00 | Underweight ➝ Underweight | |
LMND Lemonade | Target Raised by | Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $17.48 -2.5% | $14.00 ➝ $16.00 | Underperform ➝ Underperform | |
LNZA LanzaTech Global | Initiated by | TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $2.74 -3.9% | $3.00 | Hold | |
LOW Lowe's Companies | Target Lowered by | Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $231.46 -0.1% | $243.00 ➝ $240.00 | Neutral ➝ Neutral | |
LXU LSB Industries | Target Raised by | Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $8.67 +0.1% | $8.00 ➝ $9.00 | Underweight ➝ Underweight | |
LYEL Lyell Immunopharma | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $2.54
| $6.00 | Buy ➝ Buy | |
LYRA Lyra Therapeutics | Downgraded by | Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $0.42 -19.5% | | Buy ➝ Underperform | |
LYRA Lyra Therapeutics | Downgraded by | Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $0.42 -19.5% | $10.00 ➝ $0.50 | Buy ➝ Hold | |
LYRA Lyra Therapeutics | Downgraded by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $0.42 -19.5% | $12.00 ➝ $2.00 | Buy ➝ Neutral | |
MCHP Microchip Technology | Target Raised by | TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $92.06 -1.8% | $80.00 ➝ $90.00 | Hold ➝ Hold | |
MCHP Microchip Technology | Target Raised by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $92.06 -1.8% | $90.00 ➝ $100.00 | Buy ➝ Buy | |
MCHP Microchip Technology | Target Raised by | Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $92.06 -1.8% | $82.00 ➝ $85.00 | Neutral ➝ Neutral | |
MCHP Microchip Technology | Target Raised by | Susquehanna Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $92.06 -1.8% | $100.00 ➝ $105.00 | Positive ➝ Positive | |
MCHP Microchip Technology | Target Raised by | Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $92.06 -1.8% | $100.00 ➝ $104.00 | Buy ➝ Buy | |
MCHP Microchip Technology | Target Raised by | UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $92.06 -1.8% | $95.00 ➝ $103.00 | Buy ➝ Buy | |
MCHP Microchip Technology | Reiterated by | Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $92.06 -1.8% | $80.00 ➝ $90.00 | Neutral ➝ Neutral | |
MCHP Microchip Technology | Target Raised by | The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $92.06 -1.8% | $77.00 ➝ $88.00 | Neutral ➝ Neutral | |
MCHP Microchip Technology | Target Raised by | Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $92.06 -1.8% | $93.00 ➝ $96.00 | Buy ➝ Buy | |
MCHP Microchip Technology | Target Raised by | B. Riley Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $92.06 -1.8% | $105.00 ➝ $110.00 | Buy ➝ Buy | |
MCHP Microchip Technology | Target Raised by | KeyCorp Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $92.06 -1.8% | $90.00 ➝ $110.00 | Overweight ➝ Overweight | |
MCO Moody's | Target Raised by | Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $393.97 +1.6% | $350.00 ➝ $374.00 | Hold ➝ Hold | |
MET MetLife | Target Lowered by | Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $71.26 +0.1% | $87.00 ➝ $86.00 | Outperform ➝ Outperform | |
MGX Metagenomi | Initiated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $6.46 -0.2% | $10.00 | Buy | |
MITT AG Mortgage Investment Trust | Target Raised by | Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $6.80 +0.9% | $7.00 ➝ $7.50 | Market Perform ➝ Market Perform | |
MNTK Montauk Renewables | Target Lowered by | B. Riley Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $4.11 +4.6% | $7.00 ➝ $6.00 | Neutral ➝ Neutral | |
MODN Model N | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $29.77 +0.3% | | Hold | |
MOS Mosaic | Target Lowered by | Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $29.88 +2.9% | $32.00 ➝ $29.00 | Underweight ➝ Underweight | |
MRNA Moderna | Target Raised by | UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $121.07 -0.9% | $143.00 ➝ $151.00 | Buy ➝ Buy | |
MRNS Marinus Pharmaceuticals | Target Lowered by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $1.57 +6.1% | $27.00 ➝ $11.00 | Buy ➝ Buy | |
MTZ MasTec | Target Raised by | DA Davidson Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $105.65 -0.2% | $100.00 ➝ $120.00 | Buy ➝ Buy | |
MYPS PLAYSTUDIOS | Reiterated by | Benchmark Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $2.42 +3.9% | $5.00 | Buy ➝ Buy | |
NCMI National CineMedia | Reiterated by | Benchmark Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $4.61 -4.6% | $6.00 | Speculative Buy ➝ Speculative Buy | |
NCMI National CineMedia | Reiterated by | Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $4.61 -4.6% | $5.50 | Neutral | |
NEE NextEra Energy | Target Raised by | BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $71.95 +1.0% | $72.00 ➝ $78.00 | Outperform ➝ Outperform | |
Tech GIANT’s Plans to Revolutionize Crypto… (Ad) A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products.
If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE…
The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.
Claim your free seat by clicking here now. |
NET Cloudflare | Upgraded by | DZ Bank Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $74.13 -0.2% | $95.00 | Hold ➝ Buy | |
NGVT Ingevity | Target Raised by | Loop Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $53.72 -0.2% | $49.00 ➝ $56.00 | Hold ➝ Hold | |
NMIH NMI | Target Raised by | Compass Point Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $33.66 +0.7% | $33.00 ➝ $36.00 | Buy ➝ Buy | |
NOW ServiceNow | Reiterated by | JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $713.33 -1.8% | $825.00 | Market Outperform ➝ Market Outperform | |
NOW ServiceNow | Reiterated by | William Blair Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $713.33 -1.8% | | Outperform | |
NOW ServiceNow | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $713.33 -1.8% | $900.00 | Buy ➝ Buy | |
NOW ServiceNow | Target Raised by | Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $713.33 -1.8% | $870.00 ➝ $885.00 | Outperform ➝ Outperform | |
NREF NexPoint Real Estate Finance | Target Lowered by | Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $13.37 +1.7% | $14.00 ➝ $13.50 | Market Perform ➝ Market Perform | |
NSSC Napco Security Technologies | Target Raised by | B. Riley Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $45.74 +1.0% | $36.00 ➝ $45.00 | Neutral ➝ Neutral | |
NSSC Napco Security Technologies | Target Raised by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $45.74 +1.0% | $46.00 ➝ $52.00 | Buy ➝ Buy | |
NVDA NVIDIA | Target Raised by | The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $905.54 -1.7% | $1,000.00 ➝ $1,100.00 | Buy ➝ Buy | |
NWN Northwest Natural | Target Raised by | Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $38.37 +1.3% | $39.00 ➝ $40.00 | Buy ➝ Buy | |
OMC Omnicom Group | Upgraded by | Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $94.70 +1.6% | $100.00 ➝ $110.00 | Equal Weight ➝ Overweight | |
OMGA Omega Therapeutics | Reiterated by | Chardan Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $2.16 -5.3% | $7.00 ➝ $7.00 | Buy ➝ Buy | |
ONON ON | Reiterated by | Telsey Advisory Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $34.01 -0.1% | $37.00 ➝ $37.00 | Outperform ➝ Outperform | |
OPAD Offerpad Solutions | Target Lowered by | The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $6.74 -7.2% | $7.00 ➝ $6.00 | Neutral ➝ Neutral | |
OPAD Offerpad Solutions | Target Lowered by | JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $6.74 -7.2% | $12.00 ➝ $9.00 | Market Outperform ➝ Market Outperform | |
ORIC ORIC Pharmaceuticals | Target Lowered by | Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $9.61 +2.6% | $15.00 ➝ $14.00 | Buy ➝ Buy | |
OVID Ovid Therapeutics | Target Lowered by | Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $3.00 -0.7% | $4.00 ➝ $3.50 | Neutral ➝ Neutral | |
PAY Paymentus | Target Raised by | Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $19.21 -13.5% | $20.00 ➝ $22.00 | Neutral ➝ Neutral | |
PAY Paymentus | Target Raised by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $19.21 -13.5% | $19.00 ➝ $21.00 | Equal Weight ➝ Equal Weight | |
PAY Paymentus | Target Raised by | Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $19.21 -13.5% | $22.00 ➝ $23.00 | Neutral ➝ Neutral | |
PHG Koninklijke Philips | Upgraded by | BNP Paribas Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $26.51 -1.4% | | Underperform ➝ Neutral | |
PLCE Children's Place | Target Lowered by | Telsey Advisory Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $9.35 +16.4% | $13.00 ➝ $9.00 | Market Perform ➝ Market Perform | |
PLRX Pliant Therapeutics | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $13.79
| $38.00 | Buy ➝ Buy | |
PLRX Pliant Therapeutics | Target Raised by | Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $13.79
| $47.00 ➝ $48.00 | Outperform ➝ Outperform | |
PLRX Pliant Therapeutics | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $13.79
| $36.00 | Buy ➝ Buy | |
PLRX Pliant Therapeutics | Target Lowered by | Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $13.79
| $54.00 ➝ $45.00 | Outperform ➝ Outperform | |
PLRX Pliant Therapeutics | Target Lowered by | Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $13.79
| $45.00 ➝ $44.00 | Buy ➝ Buy | |
PLTR Palantir Technologies | Target Raised by | Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $21.40 -15.1% | $18.00 ➝ $20.00 | Sell ➝ Sell | |
PLTR Palantir Technologies | Reiterated by | William Blair Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $21.40 -15.1% | | Underperform | |
PLTR Palantir Technologies | Target Raised by | HSBC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $21.40 -15.1% | $22.00 ➝ $23.00 | Hold ➝ Hold | |
PLTR Palantir Technologies | Target Raised by | Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $21.40 -15.1% | $23.00 ➝ $25.00 | Neutral ➝ Neutral | |
PLTR Palantir Technologies | Target Raised by | Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $21.40 -15.1% | $5.00 ➝ $9.00 | Underperform ➝ Underperform | |
PLTR Palantir Technologies | Target Raised by | DA Davidson Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $21.40 -15.1% | $19.00 ➝ $24.00 | Neutral ➝ Neutral | |
PNTG The Pennant Group | Reiterated by | Stephens Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $20.91 -3.1% | $23.00 | Overweight ➝ Overweight | |
PODD Insulet | Upgraded by | Wolfe Research Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $184.28 +4.5% | $200.00 | Peer Perform ➝ Outperform | |
POST Post | Target Raised by | Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $105.43 +0.0% | $115.00 ➝ $120.00 | Overweight ➝ Overweight | |
PRAA PRA Group | Reiterated by | JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $25.04 -1.1% | $33.00 | Market Outperform ➝ Market Outperform | |
PRFT Perficient | Reiterated by | Maxim Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $73.28 +0.0% | $76.00 | Buy ➝ Hold | |
PRFT Perficient | Reiterated by | Barrington Research Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $73.28 +0.0% | | Outperform ➝ Market Perform | |
PRFT Perficient | Reiterated by | Alliance Global Partners Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $73.28 +0.0% | | Buy ➝ Neutral | |
PRME Prime Medicine | Reiterated by | Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $5.57 +3.1% | $23.00 ➝ $15.00 | Buy ➝ Buy | |
PTLO Portillo's | Reiterated by | Stephens Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $10.61 -12.5% | $20.00 | Overweight ➝ Overweight | |
PTON Peloton Interactive | Reiterated by | Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $4.09 +15.5% | | Outperform | |
PWR Quanta Services | Target Raised by | Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $266.88 -1.0% | $255.00 ➝ $288.00 | Outperform ➝ Outperform | |
PWR Quanta Services | Target Raised by | DA Davidson Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $266.88 -1.0% | $225.00 ➝ $250.00 | Neutral ➝ Neutral | |
PYXS Pyxis Oncology | Reiterated by | Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $4.38 +1.6% | $10.00 | Buy ➝ Buy | |
QCOM QUALCOMM | Target Raised by | Argus Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $180.15 -0.9% | $180.00 ➝ $205.00 | Buy ➝ Buy | |
RANI Rani Therapeutics | Target Raised by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $7.46 -1.3% | $12.00 ➝ $13.00 | Buy ➝ Buy | |
RCKT Rocket Pharmaceuticals | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $23.36 +0.7% | $53.00 | Buy ➝ Buy | |
RGA Reinsurance Group of America | Target Raised by | Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $203.22 +1.1% | $220.00 ➝ $235.00 | Outperform ➝ Outperform | |
RKLB Rocket Lab USA | Target Lowered by | Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $3.97 -2.2% | $6.00 ➝ $5.45 | Buy ➝ Buy | |
RKT Rocket Companies | Target Raised by | Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $13.98 +1.2% | $12.00 ➝ $13.00 | Neutral ➝ Neutral | |
ROOT Root | Reiterated by | Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $62.97 +11.2% | $70.00 ➝ $80.00 | Outperform ➝ Outperform | |
RXST RxSight | Target Raised by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $62.19 -1.0% | $61.00 ➝ $68.00 | Overweight ➝ Overweight | |
RXST RxSight | Target Raised by | Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $62.19 -1.0% | $61.00 ➝ $72.00 | Outperform ➝ Outperform | |
RXST RxSight | Target Raised by | BTIG Research Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $62.19 -1.0% | $61.00 ➝ $72.00 | Buy ➝ Buy | |
RXST RxSight | Target Raised by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $62.19 -1.0% | $64.00 ➝ $75.00 | Buy ➝ Buy | |
RYTM Rhythm Pharmaceuticals | Target Lowered by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $39.35 -10.3% | $50.00 ➝ $46.00 | Buy ➝ Buy | |
SAFE Safehold | Reiterated by | JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $19.80 +3.7% | $35.00 | Market Outperform ➝ Market Outperform | |
SAVE Spirit Airlines | Target Lowered by | TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $3.32 -0.9% | $4.00 ➝ $3.00 | Hold ➝ Hold | |
SAVE Spirit Airlines | Target Lowered by | Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $3.32 -0.9% | $4.00 ➝ $3.00 | Hold ➝ Hold | |
SBOW SilverBow Resources | Target Raised by | Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $34.32 +2.4% | $45.00 ➝ $47.00 | Buy ➝ Buy | |
SEDG SolarEdge Technologies | Target Lowered by | Roth Mkm Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $58.71 -2.3% | $76.00 ➝ $60.00 | Neutral ➝ Neutral | |
SGH SMART Global | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $18.53 -0.3% | $27.00 | Buy ➝ Buy | |
SHLS Shoals Technologies Group | Target Lowered by | Roth Mkm Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $8.80 -0.6% | $20.00 ➝ $15.00 | Buy ➝ Buy | |
SHO Sunstone Hotel Investors | Upgraded by | Compass Point Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $10.38 +0.2% | $10.00 ➝ $12.00 | Sell ➝ Neutral | |
SHOP Shopify | Reiterated by | Benchmark Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $77.05 -0.4% | | Hold | |
SIBN SI-BONE | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $15.68 +8.3% | $27.00 | Buy ➝ Buy | |
SIBN SI-BONE | Reiterated by | JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $15.68 +8.3% | $32.00 | Market Outperform ➝ Market Outperform | |
SIBN SI-BONE | Target Lowered by | Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $15.68 +8.3% | $26.00 ➝ $25.00 | Overweight ➝ Overweight | |
SMMT Summit Therapeutics | Initiated by | Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $5.31 +18.8% | $7.00 | Buy | |
SNV Synovus Financial | Target Raised by | DA Davidson Subscribe to MarketBeat All Access for the recommendation accuracy rating | G. Tenner Subscribe to MarketBeat All Access for the recommendation accuracy rating | $38.38 -0.8% | $43.00 ➝ $47.00 | Buy ➝ Buy | |
SNV Synovus Financial | Reiterated by | Stephens Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $38.38 -0.8% | $38.00 | Equal Weight ➝ Equal Weight | |
SPOT Spotify Technology | Target Raised by | Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $298.05 -0.5% | $255.00 ➝ $310.00 | Neutral ➝ Neutral | |
SRRK Scholar Rock | Reiterated by | Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $14.69 -2.5% | $23.00 | Outperform | |
STOK Stoke Therapeutics | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $11.94 +0.6% | $35.00 | Buy ➝ Buy | |
STOK Stoke Therapeutics | Target Lowered by | Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $11.94 +0.6% | $21.00 ➝ $20.00 | Buy ➝ Buy | |
SXI Standex International | Target Raised by | DA Davidson Subscribe to MarketBeat All Access for the recommendation accuracy rating | M. Shlisky Subscribe to MarketBeat All Access for the recommendation accuracy rating | $166.71 -1.3% | $200.00 ➝ $203.00 | Buy ➝ Buy | |
SYM Symbotic | Target Raised by | Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $46.50 +10.9% | $52.00 ➝ $53.00 | Outperform ➝ Outperform | |
SYM Symbotic | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $46.50 +10.9% | $54.00 | Buy ➝ Buy | |
SYM Symbotic | Target Raised by | Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $46.50 +10.9% | $57.00 ➝ $58.00 | Buy ➝ Buy | |
TALO Talos Energy | Target Lowered by | Benchmark Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $12.77 -4.3% | $23.00 ➝ $20.00 | Buy ➝ Buy | |
TALO Talos Energy | Target Lowered by | Stephens Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $12.77 -4.3% | $26.00 ➝ $24.00 | Overweight ➝ Overweight | |
TBI TrueBlue | Target Lowered by | Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $10.56 -0.3% | $14.00 ➝ $13.00 | Outperform ➝ Outperform | |
TBNK Territorial Bancorp | Upgraded by | Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $8.10 -1.2% | $8.00 ➝ $8.50 | Underweight ➝ Neutral | |
TDC Teradata | Downgraded by | Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $32.72 -13.8% | $48.00 ➝ $39.00 | Neutral ➝ Underperform | |
TDC Teradata | Target Lowered by | JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $32.72 -13.8% | $72.00 ➝ $60.00 | Market Outperform ➝ Market Outperform | |
TDC Teradata | Target Lowered by | Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $32.72 -13.8% | $48.00 ➝ $44.00 | Sector Perform ➝ Sector Perform | |
TDC Teradata | Target Lowered by | Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $32.72 -13.8% | $39.00 ➝ $35.00 | Underweight ➝ Underweight | |
TDC Teradata | Target Lowered by | Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $32.72 -13.8% | $58.00 ➝ $46.00 | Outperform ➝ Outperform | |
TDC Teradata | Target Lowered by | TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $32.72 -13.8% | $46.00 ➝ $40.00 | Hold ➝ Hold | |
TDUP ThredUp | Target Lowered by | Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $1.95 +4.8% | $4.00 ➝ $3.00 | Outperform ➝ Outperform | |
TDUP ThredUp | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $1.95 +4.8% | $5.00 | Buy ➝ Buy | |
TDUP ThredUp | Target Lowered by | Telsey Advisory Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $1.95 +4.8% | $4.00 ➝ $3.00 | Outperform ➝ Outperform | |
TGLS Tecnoglass | Target Lowered by | Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $51.67 -6.3% | $65.00 ➝ $64.00 | Outperform ➝ Outperform | |
TGT Target | Upgraded by | Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $160.41 +1.3% | $180.00 | Neutral ➝ Buy | |
THS TreeHouse Foods | Target Lowered by | Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $35.51 +2.7% | $38.00 ➝ $36.00 | Hold ➝ Hold | |
THS TreeHouse Foods | Target Lowered by | TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $35.51 +2.7% | $38.00 ➝ $37.00 | Hold ➝ Hold | |
TIXT TELUS International (Cda) | Target Lowered by | Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $7.86 -1.1% | $16.50 ➝ $16.00 | Buy | |
TRTX TPG RE Finance Trust | Target Raised by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $8.84 +2.8% | $7.00 ➝ $9.00 | Overweight ➝ Overweight | |
TSN Tyson Foods | Target Raised by | BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $58.89 +0.7% | $55.00 ➝ $58.00 | Market Perform ➝ Market Perform | |
TSN Tyson Foods | Target Raised by | HSBC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $58.89 +0.7% | $48.00 ➝ $51.00 | Reduce ➝ Reduce | |
TSN Tyson Foods | Target Raised by | Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $58.89 +0.7% | $55.00 ➝ $57.00 | Neutral ➝ Neutral | |
TTI TETRA Technologies | Reiterated by | Benchmark Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $3.89 +0.8% | $8.00 | Buy ➝ Buy | |
TVTX Travere Therapeutics | Target Raised by | Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $6.75 +3.1% | $15.00 ➝ $18.00 | Buy ➝ Buy | |
TVTX Travere Therapeutics | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $6.75 +3.1% | $19.00 | Buy ➝ Buy | |
UAA Under Armour | Target Lowered by | Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $6.71 +0.4% | $8.00 ➝ $7.00 | Neutral ➝ Neutral | |
UCTT Ultra Clean | Target Raised by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $44.07 +2.6% | $50.00 ➝ $56.00 | Buy ➝ Buy | |
UCTT Ultra Clean | Target Raised by | TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $44.07 +2.6% | $47.00 ➝ $55.00 | Buy ➝ Buy | |
UHS Universal Health Services | Target Raised by | Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $169.50 +0.2% | $183.00 ➝ $189.00 | Sector Perform ➝ Sector Perform | |
ULS UL Solutions | Initiated by | Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $35.81 -0.7% | $42.00 | Buy | |
ULS UL Solutions | Initiated by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $35.81 -0.7% | $40.00 | Overweight | |
ULS UL Solutions | Initiated by | Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $35.81 -0.7% | $41.00 | Buy | |
ULS UL Solutions | Initiated by | Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $35.81 -0.7% | $40.00 | Buy | |
ULS UL Solutions | Initiated by | JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $35.81 -0.7% | $39.00 | Overweight | |
ULS UL Solutions | Initiated by | Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $35.81 -0.7% | $40.00 | Outperform | |
ULS UL Solutions | Initiated by | Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $35.81 -0.7% | $42.00 | Buy | |
ULS UL Solutions | Initiated by | UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $35.81 -0.7% | $38.00 | Neutral | |
ULS UL Solutions | Initiated by | The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $35.81 -0.7% | $39.00 | Neutral | |
ULS UL Solutions | Initiated by | Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $35.81 -0.7% | $42.00 | Outperform | |
ULS UL Solutions | Initiated by | William Blair Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $35.81 -0.7% | | Outperform | |
ULTA Ulta Beauty | Target Lowered by | Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $393.67 -0.3% | $500.00 ➝ $475.00 | Outperform ➝ Outperform | |
UPLD Upland Software | Reiterated by | Roth Mkm Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $3.36 +5.3% | $3.00 ➝ $2.50 | Sell ➝ Sell | |
USNA USANA Health Sciences | Target Lowered by | DA Davidson Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $44.74 +0.3% | $48.00 ➝ $46.00 | Neutral ➝ Neutral | |
VAC Marriott Vacations Worldwide | Target Raised by | Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $99.15 +1.7% | $115.00 ➝ $117.00 | Buy ➝ Buy | |
VALE Vale | Upgraded by | UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $12.69 +0.8% | $13.00 ➝ $15.00 | Neutral ➝ Buy | |
VIR Vir Biotechnology | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $9.93 -2.8% | $110.00 | Buy ➝ Buy | |
VMEO Vimeo | Reiterated by | Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $3.92 +3.2% | $4.00 ➝ $4.50 | Neutral ➝ Neutral | |
VRNS Varonis Systems | Target Raised by | Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $45.00 +0.9% | $56.00 ➝ $58.00 | Outperform ➝ Outperform | |
VRNS Varonis Systems | Target Raised by | Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $45.00 +0.9% | $48.00 ➝ $50.00 | Neutral ➝ Neutral | |
VRTX Vertex Pharmaceuticals | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $410.24 +1.9% | | Hold | |
VRTX Vertex Pharmaceuticals | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $410.24 +1.9% | $462.00 | Buy ➝ Buy | |
VRTX Vertex Pharmaceuticals | Target Raised by | Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $410.24 +1.9% | $450.00 ➝ $456.00 | Overweight ➝ Overweight | |
VRTX Vertex Pharmaceuticals | Target Raised by | Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $410.24 +1.9% | $417.00 ➝ $424.00 | Sector Perform ➝ Sector Perform | |
VSTS Vestis | Downgraded by | Redburn Atlantic Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $10.23 +3.2% | $13.40 | Buy ➝ Neutral | |
WES Western Midstream Partners | Target Raised by | Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $35.64
| $34.00 ➝ $39.00 | Buy ➝ Buy | |
WLK Westlake | Target Raised by | Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $156.45 +2.1% | $160.00 ➝ $180.00 | Overweight ➝ Overweight | |
WMT Walmart | Target Raised by | UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $60.62 +1.3% | $63.00 ➝ $69.00 | Buy ➝ Buy | |
WOLF Wolfspeed | Target Lowered by | Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $24.25 -6.5% | $30.00 ➝ $25.00 | Hold ➝ Hold | |
WOOF Petco Health and Wellness | Target Lowered by | Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $1.60 +0.6% | $2.85 ➝ $1.75 | Neutral ➝ Neutral | |
WRK WestRock | Target Raised by | Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $51.62 +0.4% | $42.00 ➝ $51.00 | Hold ➝ Hold | |
WSC WillScot Mobile Mini | Target Lowered by | DA Davidson Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $39.17 +2.3% | $56.00 ➝ $54.00 | Buy ➝ Buy | |
XOM Exxon Mobil | Target Raised by | UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $116.17 -0.5% | $150.00 ➝ $152.00 | Buy ➝ Buy | |
ZETA Zeta Global | Reiterated by | Roth Mkm Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $15.38 +18.3% | $21.00 | Buy ➝ Buy | |
ZETA Zeta Global | Target Raised by | Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $15.38 +18.3% | $13.00 ➝ $17.00 | Buy ➝ Buy | |
ZETA Zeta Global | Target Raised by | DA Davidson Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $15.38 +18.3% | $15.00 ➝ $19.00 | Buy ➝ Buy | |
ZETA Zeta Global | Target Raised by | Craig Hallum Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $15.38 +18.3% | $15.00 ➝ $22.00 | Buy ➝ Buy | |
ZETA Zeta Global | Target Raised by | Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $15.38 +18.3% | $15.00 ➝ $18.00 | Overweight ➝ Overweight | |
ZETA Zeta Global | Target Raised by | Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $15.38 +18.3% | $14.00 ➝ $18.00 | Outperform ➝ Outperform | |
ZETA Zeta Global | Target Raised by | Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $15.38 +18.3% | $15.00 ➝ $18.00 | Buy ➝ Buy | |
ZETA Zeta Global | Target Raised by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $15.38 +18.3% | $13.00 ➝ $18.00 | Buy ➝ Buy | |
ZETA Zeta Global | Target Raised by | Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $15.38 +18.3% | $17.00 ➝ $18.00 | Overweight ➝ Overweight | |
ZETA Zeta Global | Target Raised by | B. Riley Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $15.38 +18.3% | $15.50 ➝ $18.50 | Buy ➝ Buy | |
ZYME Zymeworks | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $9.12 +0.7% | $10.00 | Neutral ➝ Neutral | |